Elevated plasma vascular endothelial cell growth factor and thrombomodulin in juvenile diabetic patients

Clinical and Applied Thrombosis/Hemostasis

Volumn 5, Issue 1, 1999, Pages 21-24

  McLaren, Margaret ^a   Elhadd, Tarik A ^a   Greene, Stephen A ^a   Belch, Jill J J F ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Diabetes mellitus; Thrombomodulin; Vascular endothelial cell growth factor

Indexed keywords

THROMBOMODULIN; VASCULOTROPIN; VON WILLEBRAND FACTOR;

ADOLESCENT; ADULT; ARTICLE; CELL PROLIFERATION; CHILD; DRUG BLOOD LEVEL; ENDOTHELIUM CELL; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; JUVENILE DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; VASCULAR DISEASE; VASCULAR ENDOTHELIUM;

EID: 0032909012     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/107602969900500105     Document Type: Article

References (21)

1. Janka HU, Standl E, Mehnert H. Peripheral vascular disease in diabetes mellitus and its relation to cardiovascular risk factors: screening with the Doppler ultrasound technique. Diabetes Care 1980;207:13.
2. Deckert T, Poulsen JE, Larsen M. Prognosis of diabetics with diabetes onset before the age of 31. Diabetologia 1978;14:463.
3. Lorenzi M, Cagliero E, Toledo S. Glucose toxicity for human endothelial cells in culture: delayed replication, disturbed cell cycle and accelerated death. Diabetes 1985;34:621.
4. Lau CS, McLaren M, Belch JJF. Factor VIII von Willebrand factor antigen levels correlate with symptom severity in patients with Raynaud's Phenomenon. Br J Rheumatol 1991;30:433.
5. Porta M. von Willebrand factor as an indicator of endothelial cell dysfunction in diabetic microangiopathy: studies in vivo. Diabet Med 1988;14:523.
6. Esmon TC, Owen WG. Identification of an endothelial cofactor for thrombin-catalysed activation of protein C. Proc Natl Acad Sci USA 1981;78:2249.
7. Prowse CV, Farrugia A, Boulton FE, et al. A comparative study using immunological and biological assays of haemostatic responses to DDAVP infusion, venous occlusion and exercise in normal men. Thromb Haemost 1984;51:110.
8. Juhan-Vague I, Conte-Devlox B, Aillaud MF, et al. Effects of DDAVP and venous occlusion on the release of tissue-type plasminogen activator and von Willebrand factor in patients with panhypopituitarism. Thromb Res 1984;33:653.
9. Shimano H. Takahashi K, Kawakami M, et al. Elevated serum and urinary thrombomodulin levels in patients with non insulin-dependent diabetes mellitus. Clin Chem Acta 1994;225:89.
10. Gruden G, Pagano G, Romagnoli R, et al. Thrombomodulin levels in insulin-dependent diabetics with microalbuminuria. Diabet Med 1995;12:258.
11. Rinno K, Kuramoto T, Iijima T, et al. Measurement of soluble thrombomodulin in sera from various clinical stages of diabetic neuropathy. J Clin Lab Anal 1996;10:119.
12. Inukai T, Fujiwara Y, Tayama K, et al. Clinical significance of measurement of urinary and serum thrombomodulin in patients with non insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 1996;33:99.
13. Gabat S, Keller C, Kempe HP, et al. Plasma levels of thrombomodulin - a marker for microvascular complications in diabetes mellitus. J Vasc Dis 1996;25:233.
14. Ferrara N, Houck K, Jakeman L. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 1992;13:18.
15. Midy V, Plouet J. Vasculotropin vascular endothelial growth factor induces differentiation in cultured osteoblasts. Biochem Biophys Res Commun 1994;199:380.
16. Adamis AP, Miller JW, Bernal MT, et al. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 1994;118:445.
17. Murata T, Ishibashi K, Khalil A, et al. Vascular endothelial growth factor plays a role in hyperpermeability of diabetic retinal vessels. Ophthalmic Res 1995;27:48.
18. Diabetes Control and Complications Trial Research Group. The effect of intensive insulin treatment of diabetes in the development and progression of long-term complications of insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977.
19. Wilson SB, Jennings PE, Belch JJF. Detection of microvascular impairment in type-1 diabetics by laser Doppler flowmetry. Clin Physiol 1992;12:195.
20. Galajda P, Martinka E, Mokan M, Kubisz P. Endothelial markers in diabetes mellitus. Thromb Res 1997;85:63.
21. McLaren M, Jennings PE, Forbes CD, Belch JJF. Fibrinolytic response to venous occlusion in diabetics with and without microangiopathy compared to age and sex-matched control. Fibrinolysis 1990;4:95.